These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 12689738)

  • 21. Estimation of the treatment difference in multicenter trials.
    Fedorov V; Jones B; Jones M; Zhigljavsky A
    J Biopharm Stat; 2004 Nov; 14(4):1037-63. PubMed ID: 15587979
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The enrichment window approach as a means of dealing with placebo response in antidepressant clinical trials.
    Mallinckrodt CH; Prucka WR
    Clin Pharmacol Ther; 2010 Nov; 88(5):592-4. PubMed ID: 20959845
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A new population-enrichment strategy to improve efficiency of placebo-controlled clinical trials of antidepressant drugs.
    Merlo-Pich E; Alexander RC; Fava M; Gomeni R
    Clin Pharmacol Ther; 2010 Nov; 88(5):634-42. PubMed ID: 20861834
    [TBL] [Abstract][Full Text] [Related]  

  • 24. How important is exact balance in treatment and control sample sizes to evaluations?
    Elliott MN; McCaffrey DF; Lockwood JR
    J Subst Abuse Treat; 2007 Jul; 33(1):107-10. PubMed ID: 17376636
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Testing equality of correlations of two paired binary responses from two treated groups in a randomized trial.
    Pei Y; Tang ML; Wong WK; Tang NS
    J Biopharm Stat; 2011 May; 21(3):511-25. PubMed ID: 21442523
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sample size determination for hierarchical longitudinal designs with differential attrition rates.
    Roy A; Bhaumik DK; Aryal S; Gibbons RD
    Biometrics; 2007 Sep; 63(3):699-707. PubMed ID: 17825003
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Minimum risk weights for comparing treatments in stratified binomial trials.
    Mehrotra DV; Railkar R
    Stat Med; 2000 Mar; 19(6):811-25. PubMed ID: 10734285
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Unequal group sizes in randomised trials: guarding against guessing.
    Schulz KF; Grimes DA
    Lancet; 2002 Mar; 359(9310):966-70. PubMed ID: 11918933
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Threats to the validity of clinical trials employing enrichment strategies for sample selection.
    Leber PD; Davis CS
    Control Clin Trials; 1998 Apr; 19(2):178-87. PubMed ID: 9551282
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The FDA outlook of events reporting after ticagrelor or clopidogrel in the PLATO Trial: impact of sponsor censoring dates, drug discontinuation, and withdrawal of consent.
    Serebruany VL
    Cardiology; 2011; 120(3):169-71. PubMed ID: 22418766
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A nested group sequential framework for regional evaluation in global drug development program.
    Wang W; Jiang Z; Qiu J; Xia J; Guo X
    J Biopharm Stat; 2017; 27(6):945-962. PubMed ID: 28323515
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sample size calculation in multi-centre clinical trials.
    Harden M; Friede T
    BMC Med Res Methodol; 2018 Nov; 18(1):156. PubMed ID: 30497390
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adaptive biased urn randomization in small strata when blinding is impossible.
    Schouten HJ
    Biometrics; 1995 Dec; 51(4):1529-35. PubMed ID: 8589238
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sample Size Re-Estimation without Breaking the Blind in Clinical Trial.
    Wu CH
    J Biopharm Stat; 2015; 25(5):1114-29. PubMed ID: 25630031
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optimal allocation of sample sizes to multicenter clinical trials.
    Lai D; Chang KC; Rahbar MH; Moye LA
    J Biopharm Stat; 2013; 23(4):818-28. PubMed ID: 23786227
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Demographic analysis of randomized controlled trials in bladder cancer.
    Bachir BG; Shariat SF; Zlotta A; Svatek R; Black PC; Shah JB; Kassouf W; ;
    BJU Int; 2013 Mar; 111(3):419-26. PubMed ID: 22928764
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sample size estimation for GEE method for comparing slopes in repeated measurements data.
    Jung SH; Ahn C
    Stat Med; 2003 Apr; 22(8):1305-15. PubMed ID: 12687656
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A method to estimate the variance of an endpoint from an on-going blinded trial.
    Xing B; Ganju J
    Stat Med; 2005 Jun; 24(12):1807-14. PubMed ID: 15803440
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The large sample bounds on the principal strata effect with application to a prostate cancer prevention trial.
    Chiba Y
    Int J Biostat; 2012 May; 8(1):Article 12. PubMed ID: 22628357
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DSM-5 field trials in the United States and Canada, Part I: study design, sampling strategy, implementation, and analytic approaches.
    Clarke DE; Narrow WE; Regier DA; Kuramoto SJ; Kupfer DJ; Kuhl EA; Greiner L; Kraemer HC
    Am J Psychiatry; 2013 Jan; 170(1):43-58. PubMed ID: 23111546
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.